Neopride Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Vishakhapatnam, Andhra Pradesh, India, established in 2013.
2013 Vishakhapatnam, Andhra Pradesh, India Active
Last Updated:
Access Report
About Neopride Pharmaceuticals Limited

Neopride Pharmaceuticals Limited, a active public limited company, was established on 26 March 2013 in Vishakhapatnam, Andhra Pradesh, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U74140AP2013PLC086653. Registered under ROC Roc Vijayawada. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.55 Cr.

It upholds a compliant status. Its leadership includes Goluguri Ramakrishna Reddy (Director), Goluguri Sri Rama Reddy (Director), Goluguri Venkata Reddy (Director). Past directors included Raja Sekhara Reddy Tetali. Its latest AGM occurred on 30 November 2021, with the balance sheet filed on 31 March 2021. It is based at H.No. 48-15-7, Sai Paradise Apartments Srinagar, Dwaraka Nagar, Vishakhapatnam, Andhra Pradesh, 530016.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74140AP2013PLC086653

  • Registration Number

    086653

  • Incorporation Date

    26 March 2013

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹4.55 Cr

  • ROC Code

    Roc Vijayawada

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.55 Cr
  • Company Age 12 Year, 11 Months
  • Last Filing with ROC 31 Mar 2021
  • Revenue Growth **** %
  • Ebitda **** -24.81%
  • Net Worth ****
  • Total Assets **** 0.07%
Company report

Neopride Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Neopride Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Neopride Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Goluguri Ramakrishna Reddy Director 26 Mar 2013 Current
Goluguri Sri Rama Reddy Director 26 Mar 2013 Current
Goluguri Venkata Reddy Director 26 Mar 2013 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 17 Jul 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Neopride Pharmaceuticals.

Neopride Pharmaceuticals Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Neopride Pharmaceuticals revenue growth over time
Neopride Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 0.07%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
 -24.81%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Neopride Pharmaceuticals?

In 2019, Neopride Pharmaceuticals had a promoter holding of 1.10% and a public holding of 98.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Neopride Pharmaceuticals?

Unlock and access historical data on people associated with Neopride Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Neopride Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neopride Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Neopride Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Neopride Pharmaceuticals Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Neopride Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Vijayawada. was recorded as a recent event.

  • Director Appointment

    The activity Goluguri Ramakrishna Reddy was appointed as a Director was appointed as a Director on 26 Mar 2013 & has been associated with this company since 12 years 11 months . was completed.

  • Director Appointment

    Progress on Goluguri Sri Rama Reddy was appointed as a Director was appointed as a Director on 26 Mar 2013 & has been associated with this company since 12 years 11 months . was documented.

  • Director Appointment

    Progress on Goluguri Venkata Reddy was appointed as a Director was appointed as a Director on 26 Mar 2013 & has been associated with this company since 12 years 11 months . was documented.

  • Company Incorporation

    Neopride Pharmaceuticals Limited was registered on 26 Mar 2013 with Roc Vijayawada & aged 12 years 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Neopride Pharmaceuticals Limited?

The CIN of Neopride Pharmaceuticals Limited is U74140AP2013PLC086653.

Where is Neopride Pharmaceuticals Limited headquartered?

Neopride Pharmaceuticals Limited is headquartered at H.No. 48-15-7, Sai Paradise Apartments Srinagar, Dwaraka Nagar, Vishakhapatnam, Andhra Pradesh, 530016.

When was Neopride Pharmaceuticals Limited incorporated?

Neopride Pharmaceuticals Limited was incorporated on 26 March 2013.

Who are the current directors of Neopride Pharmaceuticals Limited?

The current directors of Neopride Pharmaceuticals Limited are

What is the primary industry of Neopride Pharmaceuticals Limited?

The primary industry of Neopride Pharmaceuticals Limited is Pharma.

Is Neopride Pharmaceuticals Limited a listed company?

Neopride Pharmaceuticals Limited is unlisted.

What is the capital structure of Neopride Pharmaceuticals Limited?

The authorized capital of Neopride Pharmaceuticals Limited is ₹5.00 Cr, and the paid-up capital is ₹4.55 Cr.

What is the compliance status of Neopride Pharmaceuticals Limited?

The compliance status of Neopride Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available